MFG
ABBV icon

MidWestOne Financial Group’s AbbVie ABBV Stock Holding History

MidWestOne Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$7.18M Sell
31,422
-143
-0.5% -$32.6K 0.8% 17
2025
Q3 		$7.31M Sell
31,565
-1,751
-5% -$357K 0.89% 16
2025
Q2 		$6.18M Sell
33,316
-961
-3% -$179K 0.8% 17
2025
Q1 		$7.18M Sell
34,277
-2,217
-6% -$431K 1.02% 12
2024
Q4 		$6.48M Sell
36,494
-254
-0.7% -$46.7K 0.91% 13
2024
Q3 		$7.26M Sell
36,748
-72
-0.2% -$13.4K 1% 11
2024
Q2 		$6.32M Sell
36,820
-290
-0.8% -$48K 1.14% 8
2024
Q1 		$6.76M Sell
37,110
-2,058
-5% -$355K 1.21% 5
2023
Q4 		$6.07M Buy
39,168
+1,444
+4% +$211K 1.15% 4
2023
Q3 		$5.62M Buy
37,724
+1,280
+4% +$188K 1.27% 4
2023
Q2 		$4.91M Buy
36,444
+3,481
+11% +$510K 1.06% 7
2023
Q1 		$5.25M Sell
32,963
-345
-1% -$52.7K 1.19% 4
2022
Q4 		$5.38M Sell
33,308
-2,669
-7% -$409K 1.2% 6
2022
Q3 		$4.83M Buy
35,977
+302
+0.8% +$43.3K 1.23% 6
2022
Q2 		$5.46M Buy
35,675
+986
+3% +$151K 1.35% 4
2022
Q1 		$5.62M Sell
34,689
-2,415
-7% -$351K 1.21% 5
2021
Q4 		$5.02M Sell
37,104
-2,577
-6% -$304K 1.05% 7
2021
Q3 		$4.28M Buy
39,681
+547
+1% +$62.5K 1% 8
2021
Q2 		$4.41M Sell
39,134
-1,330
-3% -$150K 1.04% 8
2021
Q1 		$4.38M Buy
40,464
+12,829
+46% +$1.37M 1.06% 7
2020
Q4 		$2.96M Sell
27,635
-10,806
-28% -$1.04M 0.81% 11
2020
Q3 		$3.37M Buy
38,441
+6,360
+20% +$599K 1.12% 9
2020
Q2 		$3.15M Sell
32,081
-4,543
-12% -$400K 1.32% 6
2020
Q1 		$2.79M Sell
36,624
-40
-0.1% -$3.41K 1.03% 10
2019
Q4 		$3.25M Sell
36,664
-194
-0.5% -$16.1K 0.67% 10
2019
Q3 		$2.79M Sell
36,858
-405
-1% -$27.8K 0.86% 11
2019
Q2 		$2.71M Buy
+37,263
New +$2.93M 0.74% 16

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

MidWestOne Financial Group's ABBV Position: Q4 2025 in Review

MidWestOne Financial Group reduced its AbbVie (ABBV) stake by 0.45% in Q4 2025, selling an estimated $32.6K and leaving 31,422 shares worth $7.18M. The position accounts for 0.8% of the portfolio, ranked #17.

MidWestOne Financial Group first reported a position in ABBV in Q2 2019 and has held it in 27 quarters since. The position peaked at $7.31M in Q3 2025. 4,145 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • MidWestOne Financial Group held 31,422 shares of AbbVie worth $7.18M as of Q4 2025.
  • MidWestOne Financial Group sold 143 AbbVie shares in Q4 2025, an estimated $32.6K.
  • AbbVie made up 0.8% of MidWestOne Financial Group's portfolio in Q4 2025, its #17 holding.
  • MidWestOne Financial Group first reported a position in AbbVie in Q2 2019 and has held it in 27 quarters since.
  • MidWestOne Financial Group's AbbVie position peaked at $7.31M in Q3 2025.
  • 4,145 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on MidWestOne Financial Group's 13F filing for Q4 2025, filed 12 Feb 2026.